Intraoperative ex-vivo epifluorescent diagnostics of stereotactic brain biopsies using EndoScell scanner: diagnostic accuracy study
- PMID: 39833638
- DOI: 10.1007/s10143-025-03216-7
Intraoperative ex-vivo epifluorescent diagnostics of stereotactic brain biopsies using EndoScell scanner: diagnostic accuracy study
Abstract
Brain biopsy is commonly employed for the histological diagnosis of complex intracranial diseases. To improve the positive diagnostic rate, the precision of intraoperative tissue sampling is critical. This study evaluated the accuracy of fluorescence imaging technology in rapidly distinguishing tumours from nontumour tissue during surgery, thus providing real-time feedback to surgeons and optimizing the surgical workflow. Biopsy samples from 65 patients were selected for this study. The lesion tissues were sequentially stained with sodium fluorescein and methylene blue, followed by fluorescence imaging via a handheld EndoScell scanner under an intraoperative cellular microscope. Frozen section examinations and haematoxylin-eosin (HE) staining were performed on the same lesion tissue by the pathology department. The time required for fluorescence imaging and pathology of frozen sections was recorded. The results of fluorescence imaging (whether the tissue was a tumour or nontumour tissue) and frozen pathology (whether the tissue was a tumour or nontumour tissue) were also recorded. The HE staining results were used as the final gold standard for diagnosis. The sensitivity, specificity, area under the curve (AUC), Kappa consistency test, and diagnostic efficiency of both methods were calculated. Lesion tissue and diagnostic results were successfully obtained from all 65 patients. When HE-stained histopathology was used as the gold standard, the sensitivity of fluorescence imaging was 100% (95% CI: 0.917-1.000), and the specificity was 63.6% (95% CI: 0.316-0.876). In comparison, the sensitivity of frozen section pathology was 88.9% (95% CI: 0.767-0.954), and the specificity was 100% (95% CI: 0.679-1.000). Both methods demonstrated high diagnostic accuracy. ROC curve analysis revealed that the AUCs for fluorescence imaging and frozen pathology were 0.818 and 0.944, respectively, with no significant difference observed in diagnostic performance (Z = 1.597, P > 0.05). Kappa consistency tests indicated that the Kappa value for frozen pathology compared with HE staining was 0.730 (P < 0.001); for fluorescence imaging compared with HE staining, the Kappa value was 0.744 (P < 0.001), thus demonstrating strong agreement with the HE staining results for both methods. In terms of time efficiency, fluorescence imaging was significantly faster than frozen section pathology [6 (4, 7) min vs. 48 (46, 55) min, Z=-9.856, P < 0.001], thus showing a clear advantage regarding time efficiency for fluorescence imaging. Intraoperative fluorescence imaging via an EndoScell scanner, which represents a novel method for histopathological diagnosis, has high diagnostic accuracy and efficiency. This method provides real-time guidance for tissue sampling strategies in brain biopsy, thereby improving the positive diagnostic rate and reducing surgical risk.
Keywords: Brain biopsy; Fluorescence imaging; Frozen pathology; Histopathology; Stereotaxic techniques.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: The study was approved by the ethics committee of Xuanwu Hospital, and All patients provided written informed consent. Competing interests: The authors declare no competing interests.
References
-
- Kickingereder P, Willeit P, Simon T et al (2013) Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 72(6):873–882. https://doi.org/10.1227/NEU.0b013e31828bf445 - DOI - PubMed
-
- Tilgner J, Herr M, Ostertag C et al (2005) Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis–influence of clinical factors. Neurosurgery 56(2):257–265. https://doi.org/10.1227/01.neu.0000148899.39020.87 - DOI - PubMed
-
- Bauchet L, Zouaoui S, Darlix A et al (2014) Assessment and treatment relevance in elderly glioblastoma patients. Neuro Oncol 16(11):1459–1468. https://doi.org/10.1093/neuonc/nou063 - DOI - PubMed - PMC
-
- Kellermann SG, Hamisch CA, Rueß D et al (2017) Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision. J Neurooncol 134(2):303–307. https://doi.org/10.1007/s11060-017-2522-9 - DOI - PubMed
-
- Quick-Weller J, Tichy J, Dinc N et al (2017) Benefit and complications of Frame-based stereotactic biopsy in old and very old patients. World Neurosurg 102:442–448. https://doi.org/10.1016/j.wneu.2017.03.059 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical